Natco Pharma announces tentative approval for Armodafinil 50mg, 150mg, and 250mg Tablets
From USFDA
Natco Pharma announced that its marketing partner in the USA, Breckenridge Pharmaceutical Inc., has received tentative approval from the United States Food & Drug Adminstration (USFDA) for Armodafinil 50mg, 150mg, and 250mg TabletsPowered by Capital Market - Live News
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 21 2014 | 1:07 PM IST